Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Arctic Bioscience AS ( (DE:9TD) ) has issued an update.
Arctic Bioscience AS has announced a new funding arrangement, including a NOK 15 million convertible loan facility. This funding involves investments from primary insiders and their closely related companies, indicating strong internal support and confidence in Arctic Bioscience’s future prospects. This financial boost could enhance the company’s operations, particularly in advancing their pharmaceutical developments and expanding their market reach.
More about Arctic Bioscience AS
Arctic Bioscience is a biotech company that develops and commercializes pharmaceutical and nutraceutical products derived from unique bioactive marine compounds. The company is known for developing HRO350, an innovative oral drug candidate for treating mild-to-moderate psoriasis, and offers nutraceuticals globally under the ROMEGA® brand.
YTD Price Performance: 30.0%
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €4.96M
For detailed information about 9TD stock, go to TipRanks’ Stock Analysis page.
